Agilent Technologies has a long history of building nucleic acids. Originating through Agilent’s spin-off from Hewlett-Packard Company, our DNA oligonucleotide synthesis technology is based on the concepts that enable ink-jet printing. This platform empowers the printing of up to a million oligo features on a single chip, creating highly complex oligo pools with each oligo present in precise ratios. The advanced chemistries developed at Agilent also enables the printing of longer oligos than are typically available from commercial suppliers. We have harnessed this technology to develop a wide range of market-leading products including SurePrint custom microarrays, SureSelect for NGS target enrichment, SureFISH probes, and the QuikChange HT mutagenesis kit for protein engineering. Whether you are looking for the highest quality pre-defined content or you need to create your oligo libraries from the ground-up, Agilent has a solution for your CRISPR needs.
